Rating Change
B. Riley Securities analysts initiated coverage on Whitehawk Therapeutics Inc (NASDAQ:WHWK) with a Buy rating on June 25, 2026.
Rating Change B. Riley Securities analysts initiated coverage on Whitehawk Therapeutics Inc (NASDAQ:WHWK) with a Buy rating on June 25, 2026. Market Context Whitehawk Therapeutics…

B. Riley Securities analysts initiated coverage on Whitehawk Therapeutics Inc (NASDAQ:WHWK) with a Buy rating on June 25, 2026.
Whitehawk Therapeutics Inc operates in the Healthcare sector. The stock currently trades at $4.11 with a market capitalization of $117.8M. The stock has gained 125.1% over the past 52 weeks.
Analyst coverage from B. Riley Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Whitehawk Therapeutics Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 3 most recent ratings: 3 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 25, 2026 | B. Riley Securities | Buy | N/A |
| Apr 16, 2026 | Citizens | Market Outperform | N/A |
| Dec 22, 2025 | Jones Trading | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View WHWK Stock Page
A Buy rating from B. Riley Securities reflects the analyst's outlook on Whitehawk Therapeutics Inc (NASDAQ:WHWK). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the WHWK forecast page.
Current market data
NASDAQ · WHWK
$4.19
Down: -$0.12 · -2.86%
Live quote updated
Keep reading